Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies (Q44859634)

6 December 2017

Spontaneous T cell apoptosis in feline immunodeficiency virus (FIV)-infected cats is inhibited by IL2 and anti-B7.1 antibodies (English)

1 reference

feline immunodeficiency virus

6 December 2017

object named as

feline immunodeficiency virus

1 reference

4

Ellen W Collisson

1 reference

6 December 2017

Marta E Bull

1

1 reference

6 December 2017

Thomas W Vahlenkamp

2

1 reference

6 December 2017

Janet L Dow

3

1 reference

6 December 2017

Barbara J Winslow

5

1 reference

6 December 2017

Anagha P Phadke

6

1 reference

6 December 2017

Mary B Tompkins

7

1 reference

6 December 2017

Wayne A F Tompkins

8

1 reference

6 December 2017

1 May 2004

1 reference

Veterinary Immunology and Immunopathology

6 December 2017

1 reference

6 December 2017

99

1 reference

6 December 2017

1-2

1 reference

6 December 2017

25-37

1 reference

Expression of CD80 and CD86 on peripheral blood T lymphocytes in patients with systemic lupus erythematosus

6 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Functional expression of B7/BB1 on activated T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Macrophage-dependent apoptosis of CD4+ T lymphocytes from HIV-infected individuals is mediated by FasL and tumor necrosis factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Dynamic correlation of apoptosis and immune activation during treatment of HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Professional presentation of antigen by activated human T cells

7 January 2021

2 references

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

7 January 2021

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Anergic T cells act as suppressor cells in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Development of clinical disease in cats experimentally infected with feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Apoptosis occurs predominantly in bystander cells and not in productively infected cells of HIV- and SIV-infected lymph nodes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Uncovering of functional alternative CTLA-4 counter-receptor in B7-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

HIV-1 directly kills CD4+ T cells by a Fas-independent mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Progressive expansion of an L-selectin-negative CD8 cell with anti-feline immunodeficiency virus (FIV) suppressor function in the circulation of FIV-infected cats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Common epitope in human immunodeficiency virus (HIV) I-GP41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV I-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Clinical Outcome of Patients with HIV-1 Infection according to Immunologic and Virologic Response after 6 Months of Highly Active Antiretroviral Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

CTLA4 mediates antigen-specific apoptosis of human T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Selective loss of T cell functions in different stages of HIV infection. Early loss of anti-CD3-induced T cell proliferation followed by decreased anti-CD3-induced cytotoxic T lymphocyte generation in AIDS-related complex and AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: pharmacological modulation in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Spontaneous programmed cell death (PCD) process of lymphocytes of FIV-infected cats: cellular targets and modulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Immunological studies in the acquired immunodeficiency syndrome. II. Active suppression or intrinsic defect--investigated by mixing AIDS cells with HLA-DR identical normal cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

CD80 and CD86 costimulatory molecules on circulating T cells of HIV infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

CTLA-4 engagement inhibits IL-2 accumulation and cell cycle progression upon activation of resting T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

T cells can present antigens such as HIV gp120 targeted to their own surface molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Dynamics of T lymphocyte responses: intermediates, effectors, and memory cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Immune activation correlates better than HIV plasma viral load with CD4 T-cell decline during HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Rapid feline immunodeficiency virus provirus quantitation by polymerase chain reaction using the TaqMan fluorogenic real-time detection system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Elevated interleukin-10-to-interleukin-12 ratio in feline immunodeficiency virus-infected cats predicts loss of type 1 immunity to Toxoplasma gondii

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Costimulatory pathways mediate monocyte-dependent lymphocyte apoptosis in HIV

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Binding of the B cell activation antigen B7 to CD28 costimulates T cell proliferation and interleukin 2 mRNA accumulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Binding stoichiometry of the cytotoxic T lymphocyte-associated molecule-4 (CTLA-4). A disulfide-linked homodimer binds two CD86 molecules

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Elevated relative fluorescence intensity of CD38 antigen expression on CD8+ T cells is a marker of poor prognosis in HIV infection: results of 6 years of follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Human T-cell lymphotropic virus IIIB glycoprotein (gp120) bound to CD4 determinants on normal lymphocytes and expressed by infected cells serves as target for immune attack

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Regulation of cyclin-Cdk activity in mammalian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Exogenous interleukin-2 administration corrects the cell cycle perturbation of lymphocytes from human immunodeficiency virus-infected individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Downregulation of Bcl-2, but not of Bax or Bcl-x, is associated with T lymphocyte apoptosis in HIV infection and restored by antiretroviral therapy or by interleukin 2

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Persistent upregulation of MHC class II antigen expression on T-lymphocytes from cats experimentally infected with feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

B7/BB1, the ligand for CD28, is expressed on repeatedly activated human T cells in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

CD28, CTLA-4 and their ligands: who does what and to whom?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Morphologic criteria and detection of apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Fas-independent death of activated CD4(+) T lymphocytes induced by CTLA-4 crosslinking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

A cell culture model for T lymphocyte clonal anergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Costimulation of T lymphocytes: the role of CD28, CTLA-4, and B7/BB1 in interleukin-2 production and immunotherapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Early T-helper cell defects in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Analysis of host-virus interactions in AIDS with anti-gp120 T cell clones: effect of HIV sequence variation and a mechanism for CD4+ cell depletion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Enhanced expression of CTLA-4 (CD152) on CD4+ T cells in HIV infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Antigen presentation by T cells versus professional antigen-presenting cells (APC): differential consequences for T cell activation and subsequent T cell-APC interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Prolonged immunostimulatory effect of low-dose polyethylene glycol interleukin 2 in patients with human immunodeficiency virus type 1 infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Characterization of monoclonal antibodies to feline T lymphocytes and their use in the analysis of lymphocyte tissue distribution in the cat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Feline immunodeficiency virus infection is characterized by B7+CTLA4+ T cell apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Functional and phenotypic evidence for a selective loss of memory T cells in asymptomatic human immunodeficiency virus-infected men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

Safety and efficacy of polyethylene glycol-modified interleukin-2 and zidovudine in human immunodeficiency virus type 1 infection: a phase I/II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

The B7 adhesion molecule is expressed on activated human T cells: functional involvement in T-T cell interactions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

In vivo lymphocyte tropism of feline immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

inferred from DOI database lookup

7 January 2021

based on heuristic

The role of in vitro-induced lymphocyte apoptosis in feline immunodeficiency virus infection: correlation with different markers of disease progression

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2004.01.010

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VETIMM.2004.01.010

1 reference

6 December 2017

1 reference